Jinan Tantu Chemicals Letermovir Jinan Tantu Chemicals Letermovir

X

Find Radio Compass News for Letermovir

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.pharmabiz.com/NewsDetails.aspx?aid=168699&sid=2

PHARMABIZ
22 Apr 2024

https://www.businesswire.com/news/home/20231017269974/en

BUSINESSWIRE
17 Oct 2023

https://endpts.com/fda-updates-mercks-label-for-cytomegalovirus-drug-to-include-kidney-transplant-patients/

Katherine Lewin ENDPTS
07 Jun 2023

https://www.businesswire.com/news/home/20230606005563/en

BUSINESSWIRE
06 Jun 2023

https://www.businesswire.com/news/home/20230217005097/en

BUSINESSWIRE
17 Feb 2023

https://www.fiercepharma.com/pharma/mercks-antiviral-prevymis-matches-roches-valcyte-cmv-prevention-significantly-less-toxicity

Kevin Dunleavy FIERCEPHARMA
25 Oct 2022

http://www.pharmatimes.com/news/nice_recommendation_for_msds_prevymis_after_re-evaluation_1289670

Anna Smith PharmaTimes
03 Jun 2019

https://www.fiercepharma.com/pharma/merck-s-cmv-inhibitor-prevymis-gets-nod-from-nice-for-treatment-england

Kyle Blankenship FIERCE PHARMA
30 May 2019

https://www.tga.gov.au/prescription-medicines-registration-new-chemical-entities-australia

TGA
09 Jul 2018

https://www.pharmacompass.com/pdf/news/merck-sharp-dohmes-prevymis-letermovir-receives-approval-in-europe-1516425764.pdf

EMA
19 Jan 2018

http://www.businesswire.com/news/home/20171206005351/en/New-England-Journal-Medicine-Publishes-Phase-3/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

BUSINESSWIRE
07 Dec 2017

http://www.pharmatimes.com/news/msds_prevymis_approved_for_cmv_prevention_1211224

Selina McKee PHARMA TIMES
13 Nov 2017

https://www.biospace.com/article/releases/merck-receives-positive-chmp-opinion-for-prevymis-letermovir-in-the-european-union/

BIOSPACE
13 Nov 2017

http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/11/news_detail_002844.jsp&mid=WC0b01ac058004d5c1

EMA
11 Nov 2017

http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/11/news_detail_002848.jsp&mid=WC0b01ac058004d5c1

EMA
10 Nov 2017

http://www.fiercepharma.com/marketing/merck-s-bloodied-antiviral-business-nabs-approval-for-cmv-fighter-prevymis

Tracy Staton FIERCE PHARMA
10 Nov 2017
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY